Literature DB >> 7420107

Effect of lecithin on disability and plasma free-choline levels in Friedreich's ataxia.

S Chamberlain, N Robinson, J Walker, C Smith, S Benton, C Kennard, M Swash, B Kilkenny, S Bradbury.   

Abstract

Four patients with Friedreich's ataxia took part in an open trial, in which they consumed 50-100g/day lecithin granules (containing approximately 22% phosphatidycholine) for 16 weeks, but no improvement resulted. Several unwanted effects including diarrhoea, nausea, depression, "hot flushes" and weakness were experienced. Resting levels of free-choline in plasma were within the range found in 19 normal subjects. Sixteen other patients with Friedreich's ataxia also had normal free-choline levels. Treatment with lecithin significantly increased plasma free-choline levels, but there was a trend for these to fall towards baseline levels, despite continued ingestion of lecithin.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7420107      PMCID: PMC490677          DOI: 10.1136/jnnp.43.9.843

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  15 in total

1.  Clinical description and roentgenologic evaluation of patients with Friedreich's ataxia.

Authors:  G Geoffroy; A Barbeau; G Breton; B Lemieux; M Aube; C Leger; J P Bouchard
Journal:  Can J Neurol Sci       Date:  1976-11       Impact factor: 2.104

2.  Lecithin in neurologic disorders.

Authors:  A Barbeau
Journal:  N Engl J Med       Date:  1978-07-27       Impact factor: 91.245

3.  A simple, sensitive, and specific assay for free choline in plasma.

Authors:  F L Wang; D R Haubrich
Journal:  Anal Biochem       Date:  1975-01       Impact factor: 3.365

4.  Increase in hippocampal acetylcholine after choline administration.

Authors:  M J Hirsch; J H Growdon; R J Wurtman
Journal:  Brain Res       Date:  1977-04-15       Impact factor: 3.252

5.  Lecithin can suppress tardive dyskinesia.

Authors:  J H Growdon; A J Gelenberg; J Doller; M J Hirsch; R J Wurtman
Journal:  N Engl J Med       Date:  1978-05-04       Impact factor: 91.245

6.  Choline therapy in Alzheimer's disease.

Authors:  C M Smith; M Swash; A N Exton-Smith; M J Phillips; P W Overstall; M E Piper; M R Bailey
Journal:  Lancet       Date:  1978-08-05       Impact factor: 79.321

7.  Clinical effects of choline in Alzheimer's disease.

Authors:  P Etienne; S Gauthier; G Johnson; B Collier; T Mendis; D Dastoor; M Cole; H F Muller
Journal:  Lancet       Date:  1978-03-04       Impact factor: 79.321

8.  Choline administration: activation of tyrosine hydroxylase in dopaminergic neurons of rat brain.

Authors:  I H Ulus; R J Wurtman
Journal:  Science       Date:  1976-12-03       Impact factor: 47.728

9.  Decreased synthesis of acetylcholine accompanying impaired oxidation of pyruvic acid in rat brain minces.

Authors:  G E Gibson; R Jope; J P Blass
Journal:  Biochem J       Date:  1975-04       Impact factor: 3.857

10.  Physostigmine in familial ataxias.

Authors:  R A Kark; J P Blass; M A Spence
Journal:  Neurology       Date:  1977-01       Impact factor: 9.910

View more
  2 in total

1.  Lecithin treatment in Friedreich's ataxia.

Authors:  B Pentland; C N Martyn; C R Steer; J E Christie
Journal:  Br Med J (Clin Res Ed)       Date:  1981-04-11

2.  A double-blind, placebo controlled trial of high-dose lecithin in Alzheimer's disease.

Authors:  A Little; R Levy; P Chuaqui-Kidd; D Hand
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-08       Impact factor: 10.154

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.